NasdaqGS:RGENLife Sciences
Assessing Repligen (RGEN) After Prolonged Share Price Weakness
If you are wondering whether Repligen's current share price lines up with its underlying worth, you are not alone. This article walks through what the numbers actually say about value.
Repligen's share price closed at US$132.14, with returns of a 4.3% decline over 7 days, 19.1% decline over 30 days, 19.6% decline year to date, 18.8% decline over 1 year, 25.1% decline over 3 years, and 33.9% decline over 5 years. This may signal that expectations or perceived risk have shifted over...